Home » Topics » Regulatory » Patents

Patents
RSS

BioWorld MedTech Patent Highlights: Week 35

From Current Patent Gazette

Sep. 4, 2020

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

New OX40-targeting antibodies presented by Zhengzhou Airport Baiqiao Biotechnology

Sep. 4, 2020

Beijing Sanyou Liheze Biological Technology discovers potential stem cell therapy for COPD

Sep. 4, 2020

Astellas Pharma presents new CXC3-CL1-encoding AAV vectors for retinal degeneration

Sep. 4, 2020

Spanish researchers identify new SFRP1-targeting antibodies for Alzheimer's disease

Sep. 4, 2020

University of California patents lentiviral vectors for hemoglobinopathies

Sep. 4, 2020

PTC Therapeutics discovers new compounds targeting mRNA splicing machinery

Sep. 3, 2020

Agios Pharmaceuticals identifies PKM2 and PKLR activators

Sep. 3, 2020

Researchers from Czech Republic present compounds for neurodegeneration

Sep. 3, 2020

DE Shaw Research patents Abeta aggregation inhibitors

Sep. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...